1. Home
  2. Indian Stocks
  3. Top Pharma Companies in India

Top Pharma Companies in India

Sensex 57950.38
321.43 (0.56%)
Screens:
5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×
×
×
Filter Place order

Top Pharma Companies in India as on Mar-2023


 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter Place order
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
  1. Sun Pharmaceutical Industries Ltd.
    2,30,636
    (Large Cap)
    960.00
    (-0.13%)
    54.76
    4.17
    4.31
    -0.26
    Q V PT
  2. Divis Laboratories Ltd.
    74,303
    (Large Cap)
    2783.90
    (-0.54%)
    31.06
    5.98
    17.13
    21.96
    Q V PT
  3. Dr. Reddys Laboratories Ltd.
    73,968
    (Large Cap)
    4449.40
    (0.17%)
    20.25
    3.35
    8.70
    8.70
    Q V PT
  4. Cipla Ltd.
    70,000
    (Large Cap)
    867.35
    (0.01%)
    26.53
    3.08
    8.62
    22.70
    Q V PT
  5. Apollo Hospitals Enterprise Ltd.
    61,906
    (Large Cap)
    4307.00
    (0.04%)
    61.5
    9.13
    -0.65
    14.27
    Q V+ PT
  6. Torrent Pharmaceuticals Ltd.
    51,515
    (Large Cap)
    1517.75
    (-0.29%)
    61.9
    8.07
    7.91
    4.19
    Q V PT
  7. Zydus Lifesciences Ltd.
    48,166
    (Large Cap)
    476.30
    (0.09%)
    23.34
    2.79
    10.24
    7.91
    Q V PT
  8. Max Healthcare Institute Ltd.
    45,449
    (Large Cap)
    464.00
    (-0.88%)
    71.89
    6.64
    11.35
    124.35
    Q V+ PT
  9. Abbott India Ltd.
    45,270
    (Large Cap)
    21253.90
    (-0.24%)
    48.71
    15.29
    11.13
    23.40
    Q V+ PT
  10. Alkem Laboratories Ltd.
    37,169
    (Large Cap)
    3135.80
    (0.87%)
    38.86
    3.88
    14.19
    11.42
    Q V PT
  11. Lupin Ltd.
    29,401
    (Large Cap)
    648.10
    (0.29%)
    -
    2.45
    -1.28
    -190.23
    Q V PT
  12. Aurobindo Pharma Ltd.
    27,788
    (Large Cap)
    471.60
    (-0.56%)
    20.02
    1.59
    3.28
    -3.37
    Q V PT
  13. Biocon Ltd.
    24,228
    (Large Cap)
    198.85
    (-1.46%)
    22.52
    2.68
    -7.65
    -32.55
    Q V PT
  14. Syngene International Ltd.
    23,113
    (Large Cap)
    579.30
    (0.62%)
    53.6
    6.84
    16.72
    6.62
    Q V PT
  15. Glaxosmithkline Pharmaceuticals Ltd.
    21,714
    (Large Cap)
    1292.80
    (0.86%)
    12.77
    13.37
    2.42
    3.56
    Q V PT
  16. Ipca Laboratories Ltd.
    19,810
    (Mid Cap)
    782.90
    (0.26%)
    36.53
    3.33
    11.59
    37.95
    Q V PT
  17. Fortis Healthcare Ltd.
    19,663
    (Mid Cap)
    252.10
    (-3.21%)
    281.18
    2.19
    5.98
    0.00
    Q V PT
  18. Gland Pharma Ltd.
    19,167
    (Mid Cap)
    1199.25
    (3.05%)
    19.51
    2.43
    24.37
    -23.00
    Q V+ PT
  19. Laurus Labs Ltd.
    16,289
    (Mid Cap)
    305.30
    (0.96%)
    17.68
    4.09
    20.98
    35.95
    Q V PT
  20. Narayana Hrudayalaya Ltd.
    16,253
    (Mid Cap)
    774.10
    (-2.67%)
    32.37
    8.32
    14.53
    32.55
    Q V PT
  21. Pfizer Ltd.
    16,163
    (Mid Cap)
    3510.05
    (-0.65%)
    26.07
    5.27
    5.84
    20.34
    Q V PT
  22. Ajanta Pharma Ltd.
    15,158
    (Mid Cap)
    1202.00
    (1.60%)
    24.61
    4.06
    10.99
    6.09
    Q V PT
  23. JB Chemicals & Pharmaceuticals Ltd.
    15,125
    (Mid Cap)
    1962.85
    (0.41%)
    39.5
    6.37
    12.81
    20.13
    Q V+ PT
  24. Dr. Lal Pathlabs Ltd.
    14,925
    (Mid Cap)
    1780.35
    (-0.56%)
    52.22
    9.27
    16.26
    17.77
    Q V PT
  25. Sanofi India Ltd.
    13,164
    (Mid Cap)
    5731.50
    (0.27%)
    21.21
    10.32
    5.76
    14.09
    Q V PT
  26. Global Health Ltd.
    12,865
    (Mid Cap)
    491.00
    (2.36%)
    58.8
    3.23
    6.67
    30.39
    Q V+ PT
  27. Glenmark Pharmaceuticals Ltd.
    12,556
    (Mid Cap)
    441.05
    (-0.89%)
    14.22
    1.27
    6.27
    -2.52
    Q V PT
  28. Suven Pharmaceuticals Ltd.
    12,013
    (Mid Cap)
    468.35
    (-0.75%)
    31.61
    7.44
    0.00
    0.00
    Q V PT
  29. Aster DM Healthcare Ltd.
    11,908
    (Mid Cap)
    239.55
    (0.48%)
    24.78
    2.76
    11.57
    0.00
    Q V PT
  30. Krishna Institute of Medical Sciences Ltd
    10,807
    (Mid Cap)
    1337.90
    (-0.93%)
    44.71
    6.95
    16.37
    0.00
    Q V PT
First Previous 1

Check out the List of Undervalued Pharma Stocks

Pharma sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical companies even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma companies:

News about Top Pharma Companies in India

Zydus Lifesciences informs about press release

Zydus Lifesciences has informed that it enclosed a copy of press release dated March 21, 2023 titled ‘Zydus granted Orphan Drug Designation by the USFDA for ZYIL1 in treatment of patients with Cryopyrin Associated Periodic Syndrome (CAPS)’.

The above information is a part of company’s filings submitted to BSE.

21 Mar, 2023

Zydus Lifesciences trades higher on getting orphan drug designation for ZYIL1 in treatment of patients with CAPS

ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
21 Mar, 2023

Zydus Lifesciences gets orphan drug designation for ZYIL1 in treatment of patients with CAPS

ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
21 Mar, 2023

Aurobindo Pharma informs about analyst meet

Aurobindo Pharma has informed that the officials of the Company will be participating in the investor meetings, as per the schedule attached. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. This intimation is submitted pursuant to Regulation 30(6) of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

21 Mar, 2023

Lupin inches up as its alliance partner gets USFDA’s final approval for Rocuronium Bromide Injection

Rocuronium Bromide Injection had an annual sale of around $53 million in the U.S.
21 Mar, 2023

Lupin’s alliance partner gets USFDA’s final approval for Rocuronium Bromide Injection

Rocuronium Bromide Injection had an annual sale of around $53 million in the U.S.
20 Mar, 2023

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical companies in India by Market Capitalization as of 2023.
Rank Company Market Capitalization 2023 (INR  crores)
1 Sun Pharmaceutical Industries Ltd. 2,30,636 Crore
2 Divis Laboratories Ltd. 74,303 Crore
3 Dr. Reddys Laboratories Ltd. 73,968 Crore
4 Cipla Ltd. 70,000 Crore
5 Apollo Hospitals Enterprise Ltd. 61,906 Crore
6 Torrent Pharmaceuticals Ltd. 51,515 Crore
7 Zydus Lifesciences Ltd. 48,166 Crore
8 Max Healthcare Institute Ltd. 45,449 Crore
9 Abbott India Ltd. 45,270 Crore
10 Alkem Laboratories Ltd. 37,169 Crore
Find best pharma companies to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best companies to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Abbott India Ltd. (L) Very Good 21,254 45,270 48.71 15.29 31.62 29.57
Divis Laboratories Ltd. (L) Very Good 2,784 74,303 31.06 5.98 21.56 27.91
Laurus Labs Ltd. (M) Very Good 305.3 16,289 17.68 4.09 10.50 27.60
Pfizer Ltd. (M) Very Good 3,510 16,163 26.07 5.27 16.53 23.21
Sanofi India Ltd. (M) Very Good 5,732 13,164 21.21 10.32 14.97 22.31

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Zydus Lifesciences Ltd. (L) Very Good 476.3 48,166 27.51
Abbott India Ltd. (L) Very Good 21,254 45,270 23.35
Dr. Reddys Laboratories Ltd. (L) Very Good 4,449 73,968 9.87
Torrent Pharmaceuticals Ltd. (L) Very Good 1,518 51,515 6.00
Sun Pharmaceutical Industries Ltd. (L) Very Good 960.0 2,30,636 5.54
View More

To select the best stocks from the Nifty Pharma, you can check factors like stock returns over different time frames, the Return on Equity, the Price to Earnings (P/E) ratio, Price to Book Value (P/BV) ratio, and the company’s profitability.

Companies that have performed well fundamentally are more likely to see their stock prices gain too.

Nifty Pharma Stocks with the highest revenue growth in the past five years is :

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Gland Pharma Ltd. (M) Very Good 1,199 19,167 19.51 2.43 10.98 24.37
Laurus Labs Ltd. (M) Very Good 305.3 16,289 17.68 4.09 10.50 20.98
Granules India Ltd. (M) Somewhat Good 287.1 6,822 13.57 2.64 8.96 19.13
Divis Laboratories Ltd. (L) Very Good 2,784 74,303 31.06 5.98 21.56 17.13
Alkem Laboratories Ltd. (L) Very Good 3,136 37,169 38.86 3.88 24.93 14.19

Companies with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Nifty Pharma companies that had the highest profit growth in the past five years is :

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Ipca Laboratories Ltd. (M) Very Good 782.9 19,810 36.53 3.33 19.64 37.95
Laurus Labs Ltd. (M) Very Good 305.3 16,289 17.68 4.09 10.50 35.95
Abbott India Ltd. (L) Very Good 21,254 45,270 48.71 15.29 31.62 23.40
Cipla Ltd. (L) Very Good 867.4 70,000 26.53 3.08 13.76 22.70
Divis Laboratories Ltd. (L) Very Good 2,784 74,303 31.06 5.98 21.56 21.96
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
SEBI Registered: Investment Adviser - INA000013323
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | PML Act | Grievance Redressal Process | Investor charter
© 2023 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.